D69.51
Posttransfusion purpura
Clinical Classification Guidelines
Inclusion Terms
- Posttransfusion purpura from whole blood (fresh) or blood products
- PTP
Medical Intelligence & Overview
Posttransfusion purpura (PTP) is a rare but serious immune-mediated condition that can occur after a blood transfusion. It is characterized by a sudden decrease in platelet count, leading to unusual bleeding and bruising. Typically developing 5 to 10 days after transfusion, PTP mainly affects individuals who have been previously sensitized to certain blood group antigens. Understanding its causes, symptoms, diagnosis, and management can help in recognizing and addressing this condition promptly.
Causes & Symptoms
Clinical Causes: Sensitization to blood group antigens during previous transfusions, pregnancy, or transplantation Receiving transfusions with blood components containing incompatible platelet antigens Presence of alloantibodies against platelet antigens, notably anti-HPA-1a antibodies
Key Symptoms: Unexpected and severe decrease in platelet count (thrombocytopenia) Appearance of petechiae (small red or purple spots) on the skin Unexplained bleeding, such as nosebleeds or gum bleeding Easy bruising and extensive skin hemorrhages Potential development of purpura (purple spots) and hematomas In some cases, minor bleeding episodes may precede more severe hemorrhagic events
Diagnostic & Treatment
Diagnosis Path: serological testing to detect and identify platelet-specific alloantibodies, often anti-HPA-1a or other related antibodies.
Treatment Protocols: Prompt discontinuation of the suspected blood products Administration of high-dose intravenous immunoglobulin (IVIG) to neutralize alloantibodies Use of corticosteroids to suppress immune response Platelet transfusions may be administered, typically using irradiated or HLA-matched platelets to reduce the risk of further immune response Monitoring for bleeding and supportive care as needed
Clinical Advice & FAQs
Billing Guidance
Is D69.51 a billable ICD-10 code?
Yes, D69.51 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D69.51?
Clinical documentation must specify the nature of Posttransfusion purpura and any associated comorbidities for accurate reporting.
Cite this Clinical Reference